ArticleClinical and molecular hepatology2026

Aspirin on the prevention of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: Editorial on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Nationwide cohort study with genetic risk analysis".

Teng-Yu Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.